Search
Search Results
##search.searchResults.foundPlural##
-
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1949PDF: 742HTML: 689 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
862PDF: 470HTML: 123Suppl. Files: 307 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1363PDF: 1300HTML: 92 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7396PDF: 2411HTML: 1720Table 1.: 204Table 2.: 215Table 3.: 195Table 4.: 195 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2900PDF: 681HTML: 1930figure 1: 166figure 2: 175 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1288PDF: 1075PDF: 863HTML: 156 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2218PDF: 930HTML: 297 -
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1504PDF: 930HTML: 218 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1376PDF: 810HTML: 8652Fig 3 Savini: 168Fig 2 Savini: 173Fig 1 Savini Chest TC: 180Author letter to referees: 184 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3234PDF: 1521HTML: 413 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4020PDF: 1139HTML: 1931Fig.1: 215Fig. 2: 107Table 1: 200Table2: 217Table 3: 197 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4760PDF: 1757HTML: 2701Untitled: 211 -
Anemia in the elderly: not always what it seems.
3288PDF: 1017HTML: 1769Figure 1: 172Figure 1 revised: 175 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4058PDF: 1230HTML: 1948Table 1: 191 -
THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA
2021PDF: 973HTML: 313 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1809PDF: 709HTML: 2098Untitled: 208Untitled: 150Untitled: 166Untitled: 151Untitled: 160Untitled: 174Untitled: 181 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1163PDF: 824HTML: 3352 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1077PDF: 839HTML: 234 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2158PDF: 921HTML: 404Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 211UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 339Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 237Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 176Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 188Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 256 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2764PDF: 760HTML: 1262Blood Count trend before and during lenalidomide treatment: 170Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 186 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2054PDF: 1502HTML: 269 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4704PDF: 1544HTML: 2246Untitled: 204Untitled: 219Untitled: 228Untitled: 210Untitled: 212 -
-
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2379PDF: 849HTML: 2450 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3228PDF: 1071HTML: 427 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1076PDF: 539HTML: 1683Figures: 165Fifures Sanz: 176tables Sanz: 180Untitled: 176 -







